Tokyo, Dec. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000055402) titled 'Blood LDL-C level lowering effect of oral intake of lycopene: a systematic review with meta-analysis' on Nov. 30.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - KAGOME CO., LTD.
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate whether oral intake of lycopene lowers blood LDL-C level in healthy adults
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - (PICOS)
Participant:
Healthy adults without illness (excluding pregnant women, women who plan to become pregnant and lactating women)
Intervention:
Oral intake of test food containing lycopene (regardless of the form and amount of intake)
Comparison:
Oral intake of test food without lycopene, or no intervention
Outcome measurement:
Blood LDL-C level
Study design:
Randomized controlled parallel trials (RCT-P), randomized controlled crossover trials (RCT-C), quasi-randomized controlled parallel trials (qRCT-P), quasi randomized controlled crossover trials (qRCT-C), non-randomized controlled parallel trials (nonRCT-P), non-randomized controlled crossover trials (nonRCT-C), and non-randomized controlled trials
(Language)
Eligibility is not restricted by language
Key exclusion criteria - Exclude studies that did not aim to evaluate blood lipids, proceedings and unpublished studies which don't give us enough research details, and other gray documents that are difficult to verify
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2024 Year 08 Month 09 Day
Anticipated trial start date - 2024 Year 09 Month 03 Day
Last follow-up date - 2024 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063317
Disclaimer: Curated by HT Syndication.
